New blood filter could save lives in sudden liver failure
NCT ID NCT07178366
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a blood purification device called DPMAS for people with acute-on-chronic liver failure (ACLF), a life-threatening condition. About 56 adults will be randomly assigned to standard medical care alone or standard care plus DPMAS. The goal is to see if DPMAS improves liver function and survival without needing a transplant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Double Plasma Molecular Adsorption System (DPMAS) - a blood purification device
What this could lead to
If it works, DPMAS could offer a way to stabilize liver function and improve survival without needing a transplant for people with acute-on-chronic liver failure.
What could go wrong
This is a small, early-stage trial with only 56 participants. The treatment is not a cure and may not work for everyone. There are also risks from the blood filtering procedure itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ON CHRONIC LIVER FAILURE (ACLF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••